SB-497115-GR

· GlaxoSmithKline

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for SB-497115-GR, covering 2009-12-31 to 2015-02-23. Get the full timeline:

Most recent: Clinical Trial Update: Japanese Phase II Study of SB-497115-GR in Hepatitis C Virus Infected Patients [Phase 2]